Accès ouvert
2026
article
OpenAlex
Hao Zhang, Daqiang Li, Hao-Chi Hsu, Akshay Vishwanatha et autres
Abstract Malaria remains a significant global health threat, affecting millions of lives each year. The causative agents, Plasmodium parasites, are highly resilient and have developed resistance to nearly all existing antimalarial drugs. The Plasmodium 20S proteasome core (Pf20S), a central component of …
us, Ouganda
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Masanobu Miura, Yuta Kagaya, Hiroki Saito, Kenjiro Sato et autres
Ventricular septal defect after myocardial infarction (MI-VSD) is a rare but fatal complication. This real-world database study reports the patient characteristics and outcomes after surgical repair of MI-VSD based on the Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination …
jp, be
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Daichi Terunuma, Masanobu Miura, Ko Teshima, Yuta Kagaya et autres
Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Satsuki Yagi-Nakajima, Masanobu Miura, Shun Sawada, Takahiro Funaki et autres
Myocardial calcification in myocarditis is rare and may be linked to poor outcomes. We herein report a case of fulminant myocarditis with massive myocardial calcification and its pathological outcomes at autopsy. A 49-year-old man experienced chest pain and was diagnosed with acute …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Takumi Murakami, Yutaro Otomo, Tatsuya Ito, Kenjiro Sato et autres
Pulmonary artery pseudoaneurysms (PAPs) are uncommon, yet they frequently result in hemoptysis and are associated with a poor prognosis. We report a case of an 87-year-old male patient. Initially, he was admitted to a previous hospital, and diagnosed with a lung abscess …
jp
(code pays fourni par la source)
2024
article
OpenAlex
Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa et autres
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa et autres
Results: The %Change in TG and Apo A-I levels was significantly greater with pemafibrate than with bezafibrate (-46.1% vs. -34.7%,p<0.001; 9.2% vs. 5.7%, p=0.018, respectively).%Change in HDL-C levels was not significantly different between the two treatments.%Change in liver enzyme levels was markedly …
Accès ouvert
2023
article
OpenAlex
Zenichi Ikeda, Taku Kamei, Yusuke Sasaki, Matthew Reynolds et autres
High Resolution Image Download MS PowerPoint Slide A novel series of non-amidine-based C1s inhibitors have been explored. Starting from high-throughput screening hit 3, isoquinoline was replaced with 1-aminophthalazine to enhance C1s inhibitory activity while exhibiting good selectivity against other serine proteases. We …
jp, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa et autres
Abstract Background We examined the effect of switching from angiotensin receptor-neprilysin inhibitor (ARNI) to angiotensin-receptor blocker (ARB) on plasma levels of natriuretic peptides and myocardial remodeling. Methods This is a prospective study that included 11 patients with heart failure (HF) treated with …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Hao Zhang, John D. Ginn, Wenhu Zhan, Annie Leung et autres
With increasing reports of resistance to artemisinins and artemisinin-combination therapies, targeting the Plasmodium proteasome is a promising strategy for antimalarial development. We recently reported a highly selective Plasmodium falciparum proteasome inhibitor with anti-malarial activity in the humanized mouse model. To balance the …
us, Ouganda
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa et autres
Abstract Background: We examined the effect of switching from angiotensin receptor-neprilysin inhibitor (ARNI) to angiotensin-receptor blocker (ARB) on plasma levels of natriuretic peptides and myocardial remodeling. Methods: This is a prospective study that included 11 patients with heart failure (HF) treated with …
jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa et autres
AIM: Pemafibrate is a highly selective agonist for peroxisome proliferator-activated receptor (PPAR)-α, a key regulator of lipid and glucose metabolism. We compared the efficacy and safety of pemafibrate with those of bezafibrate, a nonselective PPAR-α agonist. METHODS: In this randomized crossover study, …
jp
(code pays fourni par la source)